<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ppharm</journal-id><journal-title-group><journal-title xml:lang="ru">Педиатрическая фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pediatric pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1727-5776</issn><issn pub-type="epub">2500-3089</issn><publisher><publisher-name>Издательство «ПедиатрЪ»</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15690/pf.v11i3.1002</article-id><article-id custom-type="elpub" pub-id-type="custom">ppharm-91</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НОВЫЕ МЕДИЦИНСКИЕ ТЕХНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEW TECHNOLOGIES IN MEDICINE</subject></subj-group></article-categories><title-group><article-title>СОВРЕМЕННЫЕ ПОДХОДЫ К ОРГАНИЗАЦИИ ТРАНСЛЯЦИОННЫХ ИССЛЕДОВАНИЙ</article-title><trans-title-group xml:lang="en"><trans-title>MODERN APPROACHES TO THE ORGANIZATION OF TRANSLATIONAL RESEARCH</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колбин</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolbin</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>доктор медицинских наук, профессор, заведующий кафедрой клинической фармакологии и доказательной медицины Первого Санкт-Петербургского государственного медицинского университета им. академика И.П. Павлова; профессор кафедры фармакологии медицинского факультета Санкт-Петербургского государственного университета</p></bio><bio xml:lang="en"><p>PhD, professor, head of the department of clinical pharmacology and evidence-based medicine of Pavlov First St. Petersburg State Medical University; professor at the department of pharmacology of the medical faculty of the St. Petersburg State University</p></bio><email xlink:type="simple">Alex.kolbin@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Гапешин</surname><given-names>Р. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Gapeshin</surname><given-names>R. A.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Малышев</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Malyshev</surname><given-names>S. M.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Первый Санкт-Петербургский государственный медицинский университет им. академика И.П. Павлова&#13;
Санкт-Петербургский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pavlov First St. Petersburg State Medical University&#13;
St. Petersburg State University</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Санкт-Петербургский государственный университет, Российская Федерация</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Saint Petersburg State University, Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>03</day><month>06</month><year>2014</year></pub-date><volume>11</volume><issue>3</issue><issue-title>Педиатрическая фармакология</issue-title><fpage>15</fpage><lpage>19</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колбин А.С., Гапешин Р.А., Малышев С.М., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Колбин А.С., Гапешин Р.А., Малышев С.М.</copyright-holder><copyright-holder xml:lang="en">Kolbin A.S., Gapeshin R.A., Malyshev S.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pedpharma.ru/jour/article/view/91">https://www.pedpharma.ru/jour/article/view/91</self-uri><abstract/><trans-abstract xml:lang="en"><p>The growing distance between fundamental science and clinical medicine may bring risk of decreasing effectiveness of biomedical research. Translational research is a relatively new concept; it implies application of fundamental research results to practice (from bench to bedside) using a specific combination of research stages. As a result, it provides integrated information on safety, efficacy and effectiveness of a medical technology. However, there is no generally accepted view on aims and structure of translational research. This review presents analysis of different methodological approaches to translational research.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>трасляционные исследования</kwd><kwd>лекарственные средства</kwd><kwd>медицинские технологии</kwd></kwd-group><kwd-group xml:lang="en"><kwd>translational research</kwd><kwd>drugs</kwd><kwd>medical technologies</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Основные понятия в оценке медицинских технологий:</mixed-citation><mixed-citation xml:lang="en">Osnovnye ponyatiya v otsenke meditsinskikh tekhnologii: metod. posobie. Pod obshch. red. A.S. Kolbina, S.K. Zyryanova, D.Yu. Belousova [The Main Terms in the Evaluation of Medical Technologies: Guidance Manual. Edited by A.S. Kolbin, S.K. Zyryanov, D.Yu. Belousov. Illustrated]. Moscow, Izdatel'stvo «OKI», 2013. 42 p.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">метод. пособие. Под общ. ред. А. С. Колбина, С. К. Зырянова,</mixed-citation><mixed-citation xml:lang="en">Stafford R. S., Radley D. C. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J. Am. Coll. Cardiol. 2003; 41: 56–61.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Д. Ю. Белоусова. Москва: Издательство «ОКИ». 2013. 42 с.: ил.</mixed-citation><mixed-citation xml:lang="en">Hingwala J., Diamond J., Tangri N. et al. Underutilization of peritoneal dialysis: the role of the nephrologist's referral pattern. Nephrol. Dial. Transplant. 2013; 28 (3): 732–40.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Stafford R. S., Radley D. C. The underutilization of cardiac</mixed-citation><mixed-citation xml:lang="en">Lenfant C. Clinical Research to Clinical Practice — Lost in Translation? N. Engl. J. Med. 2003; 349: 868–874.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">medications of proven benefit, 1990 to 2002. J Am Coll Cardiol.</mixed-citation><mixed-citation xml:lang="en">Kessler R., Glasgow R. E. A proposal to speed translation of healthcare research into practice: dramatic change is needed. Am. J. Prev. Med. 2011; 40 (6): 637– 644.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">; 41: 56–61.</mixed-citation><mixed-citation xml:lang="en">High Level Pharmaceutical Forum. Core principles on relative effectiveness. 2008.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Hingwala J., Diamond J., Tangri N. et al. Underutilization of</mixed-citation><mixed-citation xml:lang="en">Kleijnen S., George E., Goulden S. et al. Relative Effectiveness Assessment of Pharmaceuticals: Similarities and Differences in 29 Jurisdictions. Value In Health. 2012; 15: 954–960.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">peritoneal dialysis: the role of the nephrologist's referral pattern.</mixed-citation><mixed-citation xml:lang="en">Ipatova O.M., Medvedeva N.V., Archakova A.I., Grigor'ev A.I. Vestnik Rossiiskoi akademii meditsinskikh nauk – Annals of the Russian Academy of Medical Sciences. 2012; 6: 57–65.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Nephrol Dial Transplant. 2013; 28 (3): 732–40.</mixed-citation><mixed-citation xml:lang="en">Van der Laan A. L., Boenink M. Beyond Bench and Bedside: Disentangling the Concept of Translational Research. Health Care Anal. 2012. Available at: http://link.springer.com</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lenfant C. Clinical Research to Clinical Practice — Lost in</mixed-citation><mixed-citation xml:lang="en">Available at: http://www.inahta.net</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Translation? N Engl J Med. 2003; 349: 868–874.</mixed-citation><mixed-citation xml:lang="en">Wagner P., Srivastava S. New paradigms in translational science research in cancer biomarkers. Translational Research. 2012; 4: 343–353.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kessler R., Glasgow R. E. A proposal to speed translation of</mixed-citation><mixed-citation xml:lang="en">Solans M., Guillamon I., Permanyer-Miralda G. et al. The impact of Spanish research on mental health: An analysis of how knowledge transfers into clinical practice through guidelines. Catalan Agency for Health Information, Assessment and Quality. 2012; 3: 35–47.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">healthcare research into practice: dramatic change is needed. Am J</mixed-citation><mixed-citation xml:lang="en">Di Sabatino A., Moschetta A., Conte D. et al. The impact of translational research on gastroenterology. Digestive and Liver Disease. 2014; 46 (4): 293–294.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Prev Med. 2011; 40 (6): 637– 644.</mixed-citation><mixed-citation xml:lang="en">Sung N. S., Crowley W. F. Jr., Genel M. et al. Central challenges facing the national clinical research enterprise. JAMA. 2003; 289: 1278–1287.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">High Level Pharmaceutical Forum. Core principles on relative</mixed-citation><mixed-citation xml:lang="en">Wehling M. Assessing the translatability of drug projects: what needs to be scored to predict success? Nat. Rev. Drug. Discov. 2009; 8: 541–546.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">effectiveness. 2008.</mixed-citation><mixed-citation xml:lang="en">Westfall J. M., Mold J., Fagnan L. Practice-based research — «blue highways» on the NIH roadmap. JAMA. 2007; 297: 403–6.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Kleijnen S., George E., Goulden S. et al. Relative Effectiveness</mixed-citation><mixed-citation xml:lang="en">Dougherty D., Conway P. H. The «3T’s» road map to transform US health care: the «how» of high-quality care. JAMA. 2008; 299: 2319–2321.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Assessment of Phar-maceuticals: Similarities and Differences in</mixed-citation><mixed-citation xml:lang="en">Drolet B., Lorenzi N. Translational research: understanding the continuum from bench to bedside. Translational Research. 2011; 1: 1–5.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Jurisdictions. Value In Health. 2012; 15: 954–960.</mixed-citation><mixed-citation xml:lang="en">Khoury M. J., Gwinn M., Yoon P. W. et al. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genetics in Medicine. 2007; 9 (10): 665–674.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Ипатова О. М., Медведева Н. В., Арчакова А. И., Григорьев А. И.</mixed-citation><mixed-citation xml:lang="en">Spoth R., Rohrbach L., Greenberg M. et al. Addressing Core Challenges for the Next Generation of Type 2 Translation Research and Systems: The Translation Science to Population Impact (TSci Impact) Framework Springer. Prevention Science. 2013. Р. 1–33.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Трансляционная медицина — путь от фундаментальной био-</mixed-citation><mixed-citation xml:lang="en">Grimshaw J., Eccles M., Lavis J. et al. Knowledge translation of research findings. Bio Med. Central Implementation Science. 2012; 7: 1–17.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">медицинской науки в здравоохранение. Вестник Российской</mixed-citation><mixed-citation xml:lang="en">Trochim W., Kane C., Graham M. J. et al. Evaluating translational research: a process marker model. Clin. Transl. Sci. 2011; 4 (3): 153–162.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">академии медицинских наук. 2012; 6: 57–65.</mixed-citation><mixed-citation xml:lang="en">Wang P., Heinssen R., Oliveri M. et al. Bridging Bench and Practice: Translational Research for Schizophrenia and Other Psychotic Disorders. Neuropsychopharmacology. 2009; 34: 204–212.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Van der Laan A. L., Boenink M. Beyond Bench and Bedside:</mixed-citation><mixed-citation xml:lang="en">Lucas D., Kincl L., Bovbjerg V. et al. Application of a translational research model to assess the progress of occupational safety research in the international commercial fishing industry. Safety Science. 2014; 64: 71–81.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Disentangling the Concept of Translational Research. Health Care</mixed-citation><mixed-citation xml:lang="en">Sarkar I., Butte A., Lussier Y. et al. Translational Bioinformatics: linking Knowledge across biological and clinical realms. J. Am. Med. Inform Assoc. 2011; 18: 354–357.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Anal. 2012. URL: http://link.springer.com</mixed-citation><mixed-citation xml:lang="en">Cimino J., Ayres E., Remennik L. et al. The National Institutes of Health’s Biomedical Translational Research Information System (BTRIS): Design, contents, functionality and experience to date. Journal of Biomedical Informatics. 2013. Available at: http://www.j-biomedinform.com</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">URL: http://www.inahta.net</mixed-citation><mixed-citation xml:lang="en">Fishburn C. Translational research: the changing landscape of drug discovery. Drug Discovery Today. 2012. pp. 1–8.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wagner P., Srivastava S. New paradigms in translational science</mixed-citation><mixed-citation xml:lang="en">Butlet D. Translational Research: crossing the value of death. Nature. 2008; 453: 840–842.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">research in cancer biomarkers. Translational Research. 2012;</mixed-citation><mixed-citation xml:lang="en">Millard W. NIH’s New NCATS: Bridging the Gulf From Bench to Bedside. Annals of Emergency Medicine. 2011; 58 (20): 13–17.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">: 343–353.</mixed-citation><mixed-citation xml:lang="en">Evans S., Scarbrough H. Supporting knowledge translation through collaborative translational research initiatives: «Bridging» versus «blurring» boundary-spanning approaches in the UK CLAHRS initiative. Social Science Medicine. 2014; 106: 119–127.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Solans M., Guillamon I., Permanyer-Miralda G. et al. The impact</mixed-citation><mixed-citation xml:lang="en">Shlyakhto E. V. Translyatsionnaya meditsina: ot nauki k praktike [Translational Medicine: from Theory to Practice]. II Mezhdunarodnyi internet-kongress spetsialistov po vnutrennim boleznyam.15.03.2013 (II International Internet Congress of Internal Medicine Specialists. Dated 15.03.2013).</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">of Spanish research on mental health: An analysis of how knowledge</mixed-citation><mixed-citation xml:lang="en">Strategiya razvitiya meditsinskoi nauki do 2025 goda. Rasporyazhenie Pravitel'stva Rossiiskoi Federatsii ot 28 dekabrya 2012 g. [Strategy of Medical Science Development till 2025. Decree of the Government of the Russian Federation dated December 28, 2012].</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">transfers into clinical practice through guidelines. Catalan Agency for</mixed-citation><mixed-citation xml:lang="en">Rossiisko-amerikanskii nauchnyi Forum po biomeditsinskim issledovaniyam. Otchet o 1-i ezhegodnoi konferentsii. Moskva. 16–18 noyabrya 2011 (Russian-American Scientific Forum on Biomedical Research. Summary of the 1st Annual Conference. Moscow. November 16-18, 2011).</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Health Information, Assessment and Quality. 2012; 3: 35–47.</mixed-citation><mixed-citation xml:lang="en">Fontana J., Alexander E., Salvatore M. Translational research in infectious disease: current paradigms and challenges ahead. Translational Research. 2012; 159 (6): 430–453.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Di Sabatino A., Moschetta A., Conte D. et al. The impact of</mixed-citation><mixed-citation xml:lang="en">Di Sabatino A., Moschetta A., Conte D. et al. The impact of</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">translational research on gastroenterology. Digestive and Liver</mixed-citation><mixed-citation xml:lang="en">translational research on gastroenterology. Digestive and Liver</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Disease. 2014; 46 (4): 293–294.</mixed-citation><mixed-citation xml:lang="en">Disease. 2014; 46 (4): 293–294.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Sung N. S., Crowley W. F. Jr., Genel M. et al. Central challenges</mixed-citation><mixed-citation xml:lang="en">Sung N. S., Crowley W. F. Jr., Genel M. et al. Central challenges</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">facing the national clinical research enterprise. JAMA. 2003;</mixed-citation><mixed-citation xml:lang="en">facing the national clinical research enterprise. JAMA. 2003;</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">: 1278–1287.</mixed-citation><mixed-citation xml:lang="en">: 1278–1287.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Wehling M. Assessing the translatability of drug projects: what</mixed-citation><mixed-citation xml:lang="en">Wehling M. Assessing the translatability of drug projects: what</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">needs to be scored to predict success? Nat Rev Drug Discov. 2009;</mixed-citation><mixed-citation xml:lang="en">needs to be scored to predict success? Nat Rev Drug Discov. 2009;</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">: 541–546.</mixed-citation><mixed-citation xml:lang="en">: 541–546.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Westfall J. M., Mold J., Fagnan L. Practice-based research —</mixed-citation><mixed-citation xml:lang="en">Westfall J. M., Mold J., Fagnan L. Practice-based research —</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">«blue highways» on the NIH roadmap. JAMA. 2007; 297: 403–6.</mixed-citation><mixed-citation xml:lang="en">«blue highways» on the NIH roadmap. JAMA. 2007; 297: 403–6.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Dougherty D., Conway P. H. The «3T’s» road map to transform</mixed-citation><mixed-citation xml:lang="en">Dougherty D., Conway P. H. The «3T’s» road map to transform</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">US health care: the «how» of high-quality care. JAMA. 2008;</mixed-citation><mixed-citation xml:lang="en">US health care: the «how» of high-quality care. JAMA. 2008;</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">: 2319–2321.</mixed-citation><mixed-citation xml:lang="en">: 2319–2321.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Drolet B., Lorenzi N. Translational research: understanding the conti-</mixed-citation><mixed-citation xml:lang="en">Drolet B., Lorenzi N. Translational research: understanding the conti-</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">nu um from bench to bedside. Translational Research. 2011; 1: 1–5.</mixed-citation><mixed-citation xml:lang="en">nu um from bench to bedside. Translational Research. 2011; 1: 1–5.</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Khoury M. J., Gwinn M., Yoon P. W. et al. The continuum of</mixed-citation><mixed-citation xml:lang="en">Khoury M. J., Gwinn M., Yoon P. W. et al. The continuum of</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">translation research in genomic medicine: how can we accelerate</mixed-citation><mixed-citation xml:lang="en">translation research in genomic medicine: how can we accelerate</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">the appropriate integration of human genome discoveries into</mixed-citation><mixed-citation xml:lang="en">the appropriate integration of human genome discoveries into</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">health care and disease prevention? Genetics in Medicine. 2007;</mixed-citation><mixed-citation xml:lang="en">health care and disease prevention? Genetics in Medicine. 2007;</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">(10): 665–674.</mixed-citation><mixed-citation xml:lang="en">(10): 665–674.</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Spoth R., Rohrbach L., Greenberg M. et al. Addressing Core</mixed-citation><mixed-citation xml:lang="en">Spoth R., Rohrbach L., Greenberg M. et al. Addressing Core</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Challenges for the Next Generation of Type 2 Translation Research</mixed-citation><mixed-citation xml:lang="en">Challenges for the Next Generation of Type 2 Translation Research</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">and Systems: The Translation Science to Population Impact</mixed-citation><mixed-citation xml:lang="en">and Systems: The Translation Science to Population Impact</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">(TSci Impact) Framework Springer. Prevention Science.</mixed-citation><mixed-citation xml:lang="en">(TSci Impact) Framework Springer. Prevention Science.</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Р. 1–33.</mixed-citation><mixed-citation xml:lang="en">Р. 1–33.</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Grimshaw J., Eccles M., Lavis J. et al. Knowledge translation</mixed-citation><mixed-citation xml:lang="en">Grimshaw J., Eccles M., Lavis J. et al. Knowledge translation</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">of research findings. Bio Med Central Implementation Science.</mixed-citation><mixed-citation xml:lang="en">of research findings. Bio Med Central Implementation Science.</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">; 7: 1–17.</mixed-citation><mixed-citation xml:lang="en">; 7: 1–17.</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Trochim W., Kane C., Graham M. J. et al. Evaluating translational</mixed-citation><mixed-citation xml:lang="en">Trochim W., Kane C., Graham M. J. et al. Evaluating translational</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">research: a process marker model. Clin Transl Sci. 2011;</mixed-citation><mixed-citation xml:lang="en">research: a process marker model. Clin Transl Sci. 2011;</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">(3): 153–162.</mixed-citation><mixed-citation xml:lang="en">(3): 153–162.</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Wang P ., Heinssen R., Oliveri M. et al. Bridging Bench and</mixed-citation><mixed-citation xml:lang="en">Wang P ., Heinssen R., Oliveri M. et al. Bridging Bench and</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Practice: Translational Research for Schizophrenia and Other</mixed-citation><mixed-citation xml:lang="en">Practice: Translational Research for Schizophrenia and Other</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Psychotic Disorders. Neuropsychopharmacology. 2009;</mixed-citation><mixed-citation xml:lang="en">Psychotic Disorders. Neuropsychopharmacology. 2009;</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">: 204–212.</mixed-citation><mixed-citation xml:lang="en">: 204–212.</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Lucas D., Kincl L., Bovbjerg V. et al. Application of a translational</mixed-citation><mixed-citation xml:lang="en">Lucas D., Kincl L., Bovbjerg V. et al. Application of a translational</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">research model to assess the progress of occupational safety</mixed-citation><mixed-citation xml:lang="en">research model to assess the progress of occupational safety</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">research in the international commercial fishing industry. Safety</mixed-citation><mixed-citation xml:lang="en">research in the international commercial fishing industry. Safety</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Science. 2014; 64: 71–81.</mixed-citation><mixed-citation xml:lang="en">Science. 2014; 64: 71–81.</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Sarkar I., Butte A., Lussier Y. et al. Translational Bioinformatics:</mixed-citation><mixed-citation xml:lang="en">Sarkar I., Butte A., Lussier Y. et al. Translational Bioinformatics:</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">linking Knowledge across biological and clinical realms. J Am</mixed-citation><mixed-citation xml:lang="en">linking Knowledge across biological and clinical realms. J Am</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Med Inform Assoc. 2011; 18: 354–357.</mixed-citation><mixed-citation xml:lang="en">Med Inform Assoc. 2011; 18: 354–357.</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Cimino J., Ayres E., Remennik L. et al. The National Institutes</mixed-citation><mixed-citation xml:lang="en">Cimino J., Ayres E., Remennik L. et al. The National Institutes</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">of Health’s Biomedical Translational Research Information System</mixed-citation><mixed-citation xml:lang="en">of Health’s Biomedical Translational Research Information System</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">(BTRIS): Design, contents, functionality and experience to date.</mixed-citation><mixed-citation xml:lang="en">(BTRIS): Design, contents, functionality and experience to date.</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Journal of Biomedical Informatics. 2013. URL: http://www.j-biomed-</mixed-citation><mixed-citation xml:lang="en">Journal of Biomedical Informatics. 2013. URL: http://www.j-biomed-</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">inform.com</mixed-citation><mixed-citation xml:lang="en">inform.com</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Fishburn C. Translational research: the changing landscape of</mixed-citation><mixed-citation xml:lang="en">Fishburn C. Translational research: the changing landscape of</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">drug discovery. Drug Discovery Today. 2012. Р. 1–8.</mixed-citation><mixed-citation xml:lang="en">drug discovery. Drug Discovery Today. 2012. Р. 1–8.</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Butlet D. Translational Research: crossing the value of death.</mixed-citation><mixed-citation xml:lang="en">Butlet D. Translational Research: crossing the value of death.</mixed-citation></citation-alternatives></ref><ref id="cit86"><label>86</label><citation-alternatives><mixed-citation xml:lang="ru">Nature. 2008; 453: 840–842.</mixed-citation><mixed-citation xml:lang="en">Nature. 2008; 453: 840–842.</mixed-citation></citation-alternatives></ref><ref id="cit87"><label>87</label><citation-alternatives><mixed-citation xml:lang="ru">Millard W. NIH’s New NCATS: Bridging the Gulf From Bench to</mixed-citation><mixed-citation xml:lang="en">Millard W. NIH’s New NCATS: Bridging the Gulf From Bench to</mixed-citation></citation-alternatives></ref><ref id="cit88"><label>88</label><citation-alternatives><mixed-citation xml:lang="ru">Bedside. Annals of Emergency Medicine. 2011; 58 (20): 13–A17.</mixed-citation><mixed-citation xml:lang="en">Bedside. Annals of Emergency Medicine. 2011; 58 (20): 13–A17.</mixed-citation></citation-alternatives></ref><ref id="cit89"><label>89</label><citation-alternatives><mixed-citation xml:lang="ru">Evans S., Scarbrough H. Supporting knowledge translation</mixed-citation><mixed-citation xml:lang="en">Evans S., Scarbrough H. Supporting knowledge translation</mixed-citation></citation-alternatives></ref><ref id="cit90"><label>90</label><citation-alternatives><mixed-citation xml:lang="ru">through collaborative translational research initiatives: «Bridging»</mixed-citation><mixed-citation xml:lang="en">through collaborative translational research initiatives: «Bridging»</mixed-citation></citation-alternatives></ref><ref id="cit91"><label>91</label><citation-alternatives><mixed-citation xml:lang="ru">versus «blurring» boundary-spanning approaches in the UK</mixed-citation><mixed-citation xml:lang="en">versus «blurring» boundary-spanning approaches in the UK</mixed-citation></citation-alternatives></ref><ref id="cit92"><label>92</label><citation-alternatives><mixed-citation xml:lang="ru">CLAHRS initiative. Social Science Medicine. 2014; 106: 119–127.</mixed-citation><mixed-citation xml:lang="en">CLAHRS initiative. Social Science Medicine. 2014; 106: 119–127.</mixed-citation></citation-alternatives></ref><ref id="cit93"><label>93</label><citation-alternatives><mixed-citation xml:lang="ru">Шляхто Е. В. Трансляционная медицина: от науки к практике.</mixed-citation><mixed-citation xml:lang="en">Шляхто Е. В. Трансляционная медицина: от науки к практике.</mixed-citation></citation-alternatives></ref><ref id="cit94"><label>94</label><citation-alternatives><mixed-citation xml:lang="ru">II Международный интернет-конгресс специалистов по внутренним болезням. 15.03.2013.</mixed-citation><mixed-citation xml:lang="en">II Международный интернет-конгресс специалистов по внутренним болезням. 15.03.2013.</mixed-citation></citation-alternatives></ref><ref id="cit95"><label>95</label><citation-alternatives><mixed-citation xml:lang="ru">Стратегия развития медицинской науки до 2025 года.</mixed-citation><mixed-citation xml:lang="en">Стратегия развития медицинской науки до 2025 года.</mixed-citation></citation-alternatives></ref><ref id="cit96"><label>96</label><citation-alternatives><mixed-citation xml:lang="ru">Распоряжение Правительства Российской Федерации от 28 декабря 2012 г.</mixed-citation><mixed-citation xml:lang="en">Распоряжение Правительства Российской Федерации от 28 декабря 2012 г.</mixed-citation></citation-alternatives></ref><ref id="cit97"><label>97</label><citation-alternatives><mixed-citation xml:lang="ru">Российско-американский научный Форум по биомедицинским исследованиям. Отчет о 1-й ежегодной конференции.</mixed-citation><mixed-citation xml:lang="en">Российско-американский научный Форум по биомедицинским исследованиям. Отчет о 1-й ежегодной конференции.</mixed-citation></citation-alternatives></ref><ref id="cit98"><label>98</label><citation-alternatives><mixed-citation xml:lang="ru">Москва. 16–18 ноября 2011.</mixed-citation><mixed-citation xml:lang="en">Москва. 16–18 ноября 2011.</mixed-citation></citation-alternatives></ref><ref id="cit99"><label>99</label><citation-alternatives><mixed-citation xml:lang="ru">Fontana J., Alexander E., Salvatore M. Translational research</mixed-citation><mixed-citation xml:lang="en">Fontana J., Alexander E., Salvatore M. Translational research</mixed-citation></citation-alternatives></ref><ref id="cit100"><label>100</label><citation-alternatives><mixed-citation xml:lang="ru">in infectious disease: current paradigms and challenges ahead.</mixed-citation><mixed-citation xml:lang="en">in infectious disease: current paradigms and challenges ahead.</mixed-citation></citation-alternatives></ref><ref id="cit101"><label>101</label><citation-alternatives><mixed-citation xml:lang="ru">Translational Research. 2012; 159 (6): 430–453.</mixed-citation><mixed-citation xml:lang="en">Translational Research. 2012; 159 (6): 430–453.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
